Merck’s Arcoxia: The Outlook Isn’t Great

Bloomberg aired this brief update today, ahead of tomorrow's FDA Advisory Committee meeting.

Play Video

Outlook for Merck's Arcoxia is Bad, Bad, Bad

Bloomberg - (BLOOM)

Apr. 11, 2007. 06:25 PM EST

Tomorrow's FDA advisory board meeting is not likely to bring good news for Merck for its Merck alternative. Bloomberg interviewed analyst Ira Loss and others. (And MSNBC will no longer simulcast Imus' program...)